May your nutrient levels stay optimal, your energy stay consistent, and your GLP-1 journey stay well-supported.
Preclinical data presented at ADA 2024 showed that HM15275 delivered superior weight loss efficacy compared to semaglutide (Wegovy) and tirzepatide (Zepbound), with relatively less reductions in lean mass
With one capsule per dose, you get consistent, reproducible results in both in vitro and rodent oral-dosing protocols
Moreover, it inhibited the expression of LC3, Beclin1, PINK1, and Parkin, and promoted the expression of Mfn1, Mfn2, and OPA1
Those interested in exploring adjacent copper peptide research can review the complete GHK-Cu guide and the focused analysis of GHK-Cu topical serum research for additional protocol guidance